Planned trial of Novan's CR 2016, nitric oxide-releasing product using Nitricil technology, in patients with chronic wound infections caused by multi-drug resistant bacteria

Trial Profile

Planned trial of Novan's CR 2016, nitric oxide-releasing product using Nitricil technology, in patients with chronic wound infections caused by multi-drug resistant bacteria

Planning
Phase of Trial: Phase I/II

Latest Information Update: 22 Oct 2014

At a glance

  • Drugs CR 2016 (Primary)
  • Indications Chronic wounds; Gram-negative infections; Wound infections
  • Focus Therapeutic Use
  • Sponsors Novan Inc
  • Most Recent Events

    • 22 Oct 2014 New trial record
    • 19 Aug 2014 This trial is expected to be initiated in the first half of 2015, according to a Novan media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top